Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,529-18,540 of 23,847
Behavioral study icon
Active Not RecruitingNCT04806516

Phase II Adaptive Deep Brain Stimulation for OCD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Pittsburgh
OCDBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Baylor College of Medicine
Condition
OCD
Behavioral study icon
CompletedNCT07333638

Naltrexone Implant for Addiction

This study is completed in China. It is testing naltrexone Implant for Addiction.

In Changsha
AddictionBehavioralOver 18 Years
Countries
China
Sponsor
Shenzhen Sciencare Medical Industries Co., Ltd.
Condition
Addiction
Drug study icon
CompletedNCT02710526

Phase II Pharmacokinetics Study of CAM2038

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
AddictionDrugA study involving a medication or substance.From 19 Years to 65 Years
Countries
United States
Sponsor
Braeburn Pharmaceuticals
Condition
Addiction
Behavioral study icon
CompletedEUCTR 2017-002897-38

NFL-101 for Addiction

This study is completed in France. It is testing NFL-101 for Addiction.

In France
AddictionOther
Countries
France
Sponsor
NFL BIOSCIENCES SAS
Condition
Addiction
Drug study icon
CompletedNCT02933606

Phase II Study of BNC210 in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Oceanside
PTSDDrugFrom 18 Years to 70 Years
Countries
United States, Australia
Sponsor
Bionomics Limited
Condition
PTSD
Drug study icon
CompletedNCT00322764

RG2417 for depression

This study is completed in the United States. It is testing RG2417 for depression.

Multiple locations, including Stanford
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Repligen Corporation
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00686998

Phase IIA Study in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Rockville
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.